ロード中...
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Tumors that lack pre-existing immune infiltration respond poorly to T cell checkpoint blockade immunotherapy. These cancers often surround themselves with high densities of suppressive myeloid stroma while excluding immunostimulatory dendritic cells. Tumor-resident myeloid cells and selected lymphoc...
保存先:
| 出版年: | J Immunother Cancer |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880482/ https://ncbi.nlm.nih.gov/pubmed/31771649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0811-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|